Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009857
Filing Date
2025-05-13
Accepted
2025-05-13 09:49:17
Documents
53
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1222767
2 EX-31.1 ex31-1.htm EX-31.1 13431
3 EX-31.2 ex31-2.htm EX-31.2 13486
4 EX-32.1 ex32-1.htm EX-32.1 8233
5 EX-32.2 ex32-2.htm EX-32.2 8147
  Complete submission text file 0001641172-25-009857.txt   5687262

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sonn-20250331.xsd EX-101.SCH 38086
7 XBRL CALCULATION FILE sonn-20250331_cal.xml EX-101.CAL 40460
8 XBRL DEFINITION FILE sonn-20250331_def.xml EX-101.DEF 144195
9 XBRL LABEL FILE sonn-20250331_lab.xml EX-101.LAB 330471
10 XBRL PRESENTATION FILE sonn-20250331_pre.xml EX-101.PRE 258411
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1031134
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 25937612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)